What is LSX World Congress?
LSX was born with the simple mission to connect life science executives with the partners they need to flourish. Events now take place in London, Boston and Copenhagen.
The 9th LSX World Congress is the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core.
The event brings together the CEOs and senior decision makers from the world's most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments - all geared at putting capital and ideas to work to help create the world's future medicines and improve patient outcomes.
From therapeutics to techbio, devices to digital health, deep tech to platform tech and diagnostics to delivery tools, it represents the breadth, depth and convergence of the cutting-edge research and technology driving advances in the healthcare industry right now, and in the future.
Chief Strategy Officer, Merck KGaA
Chief Digital Officer, Roche
VP, Strategy & Business Development, Thermo Fisher Scientific
MD, Blackstone Life Sciences
President EMEA, Zimmer Biomet
Chief Digital Health Officer R&D, AstraZeneca
Managing Partner & Chairman, Sofinnova Partners
SVP & President Neuromodulation, Medtronic
General Partner, Forbion
Corporate VP Business Development, Novo Nordisk
CIO, JP Morgan Life Sciences Private Capital
Former VP Pharma Partnerships, Sidekick Health
Global Head of Digital Transformation & Innovation Execution, Novartis
CEO, OCON Healthcare
SVP, Head of Regulatory & Quality Affairs, Alexion/AstraZeneca
I had the pleasure to participate in a great session. A unique opportunity for companies, big and small.
We were delighted to be part of a fantastic event and share in the successes of our industry. Thank you for putting such a great concept in place.
Great discussions and networking. I will be back next year!